Skip to main content

Very quick update – off to the American Thoracic Society

I promised I’d try to update the blog more often to keep everyone in the loop as I just can’t seem to reply to everyone when I feel I need to do it! For the next week I’m taking the week off from planning my move (well, sort of).

For months I’ve been planning to attend the American Thoracic Society meeting in San Diego. I’ve attended this meeting for years and know many people in the ATS, both physicians and ATS staff. Honestly, when I was told I needed oxygen, I thought about not going this year. I thought about it for about five minutes. Grin!

I decided that even with all of the chaos and haste going on in my life, I HAD to be at this meeting, even more so than previous years.

First, it is an important year for Hermansky-Pudlak Syndrome at ATS. The full results of the Intermune Pirfenidone trial will be announced. Other potential drugs in the pipeline will be discussed. It’s a strategically important year to lay the groundwork for the next phase of the HPS battle, not just my own.

Second, this may sound silly as I know our researchers understand the urgency of our situation, but there’s nothing that says urgent like this darn tubing on my face. It’s visible! It’s tangible. I need a treatment now! And, as I will be driving home at every opportunity, so does the rest of the HPS community.

Lastly, and this is a more selfish reason, there are people attending this meeting who could be of great help to my personal journey. I am so lucky to have a chance to meet them and speak with them in person. I’d be a fool not to take advantage of it.

Honestly, I feel a little guilty about the last part. It’s something not everyone gets a chance to do – and everyone deserves that chance. The thing is it is impossible to take everyone to ATS. I hope that by advocating for my own needs, I’m just paving the way in some manner for everyone else. We ALL need a CURE!!!!

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria